ATP5IF1 and cancer: Herein, we have questioned: What is the relevance of a metabolic phenotype with a restrained OXPHOS in cancer onset and progression in vivo? To that aim we have generated transgenic mice that express a mutant active form of human IF1 (hIF1) under a tetracycline regulated promoter in hepatocytes.